Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somavaratan Extension Study in Adult GHD
NCT02719990Phase 2Terminated
- Sponsor
- Versartis, Inc.
- Start
- Feb 2016
- Primary completion
- Jan 2018
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 2 trial of somavaratan in growth hormone deficiency (GHD), sponsored by Versartis, Inc.. Started Feb 2016; status: terminated.
02
Drugs
somavaratan
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT02719990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719990.